Serena Corsetti

690 total citations
19 papers, 112 citations indexed

About

Serena Corsetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Serena Corsetti has authored 19 papers receiving a total of 112 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Serena Corsetti's work include Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Cancer Treatment Studies (5 papers). Serena Corsetti is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Cancer Treatment Studies (5 papers). Serena Corsetti collaborates with scholars based in Italy, United States and Germany. Serena Corsetti's co-authors include Michele Bartoletti, Sara Gagno, Giuseppe Toffoli, Rossana Roncato, Marcella Montico, Bianca Posocco, Fabio Puglisi, Domenico Sergi, Dario Didona and Giovanni Paolino and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Serena Corsetti

15 papers receiving 108 citations

Peers

Serena Corsetti

ONCOL

PRM

GENET

Iris Wang United States

Rachel Roberts‐Thomson Australia

Eugenia Ortega Spain

Giada Targato Italy

Marc Cucurull Spain

Franciszek Szubstarski Poland

Longde Lin China

Kenneth Nahum United States

Jocelyn Booth United States

Vahid Asnafi France

Iris Wang United States

Serena Corsetti

100 ×1.8

ONCOL

31 ×0.9

PRM

23 ×0.8

19 ×0.8

9 ×0.5

GENET

Citations per year, relative to Serena Corsetti Serena Corsetti (= 1×) peers Iris Wang

Countries citing papers authored by Serena Corsetti

Since Specialization

Citations

This map shows the geographic impact of Serena Corsetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Corsetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Corsetti more than expected).

Fields of papers citing papers by Serena Corsetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Corsetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Corsetti. The network helps show where Serena Corsetti may publish in the future.

Co-authorship network of co-authors of Serena Corsetti

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Corsetti. A scholar is included among the top collaborators of Serena Corsetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Corsetti. Serena Corsetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Bartoletti, Michele, Serena Corsetti, Sara Cecco, et al.. (2025). Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer. Current Oncology. 32(11). 596–596.

Bartoletti, Michele, Marcella Montico, Serena Corsetti, et al.. (2025). Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer (OC): A meta-analysis of randomized trials.. Journal of Clinical Oncology. 43(16_suppl). 5570–5570.

Posocco, Bianca, Sara Gagno, Marcella Montico, et al.. (2024). Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method. Therapeutic Drug Monitoring. 46(4). 485–493. 3 indexed citations

Schettini, Francesco, Silvana Saracchini, Serena Corsetti, et al.. (2024). Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study. The Breast. 76. 103753–103753. 1 indexed citations

Gagno, Sara, Marcella Montico, Rossana Roncato, et al.. (2024). Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring. International Journal of Molecular Sciences. 25(19). 10453–10453. 2 indexed citations

Posocco, Bianca, Sara Gagno, Alessia Bignucolo, et al.. (2023). LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring. Pharmaceutics. 15(5). 1524–1524. 12 indexed citations

Lisanti, C., Anna Costantini, Mattia Garutti, et al.. (2023). 458P Metastatic breast cancer: How and how often do we communicate? Results from an Italian national survey. Annals of Oncology. 34. S373–S374.

Gerratana, Lorenzo, Marcella Montico, Bianca Posocco, et al.. (2023). Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer. Biomedicine & Pharmacotherapy. 167. 115479–115479. 9 indexed citations

Roncato, Rossana, Lorenzo Gerratana, Bianca Posocco, et al.. (2023). Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure. Biomedicine & Pharmacotherapy. 164. 114906–114906. 18 indexed citations

10.

Bartoletti, Michele, Giorgio Giorda, Alessandra Viel, et al.. (2022). An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer. Current Oncology. 29(8). 5209–5212. 2 indexed citations

11.

Bartoletti, Michele, Roberta Mazzeo, Maria Grazia Vitale, et al.. (2020). Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva. International Journal of Gynecological Cancer. 30(11). 1672–1677. 18 indexed citations

12.

Saracchini, Silvana, Serena Corsetti, Ralph M. Wirtz, et al.. (2020). Abstract P1-10-23: Prediction of pathological complete response (pCR) upon neoadjuvant chemotherapy by MammaTyper® pCR score. Cancer Research. 80(4_Supplement). P1–10.

13.

Paolino, Giovanni, Elisa Moliterni, Serena Corsetti, et al.. (2019). Mast cells and cancer. Giornale Italiano di Dermatologia e Venereologia. 154(6). 650–668. 15 indexed citations

14.

Saracchini, Silvana, Alessandro Del Conte, Luisa Foltran, Serena Corsetti, & F Cosmi. (2019). BESTEST®: a new diagnostic opportunity for bone structure evaluation in oncology. The Breast. 44. S128–S129. 1 indexed citations

15.

Vici, Patrizia, Silvia Rossi, Claudio Botti, et al.. (2009). Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.. PubMed. 159(6). 453–6. 7 indexed citations

16.

López, Manuela G., Luigi Di Lauro, Paolo Foggi, et al.. (2009). [Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer].. PubMed. 160(6). 481–8. 2 indexed citations

17.

Vici, Patrizia, Claudio Botti, Sabrina Rossi, et al.. (2009). Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.. PubMed. 159(6). 449–52. 4 indexed citations

18.

Vici, Patrizia, Francesco Giotta, Luigi Di Lauro, et al.. (2009). Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.. PubMed. 29(5). 1841–5. 7 indexed citations

19.

Vici, Patrizia, Luigi Di Lauro, Domenico Sergi, et al.. (2008). A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines. Oncology. 75(3-4). 175–181. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact